… of this review (Nannini 2004) in order to consider separate comparisons of combination
LABA/ICS therapy with placebo (Nannini 2007a), inhaled steroids (Nannini 2010) and LABAs. …

Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus placebo for
chronic obstructive pulmonary disease - Nannini, LJ - 2013 | Cochrane Library …

Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled
corticosteroids alone for chronic obstructive pulmonary disease - Nannini, LJ - 2013 | Cochrane …

Background and Methods. The majority of asthma-related deaths occur outside the hospital,
and therefore the exact factors leading to the terminal event are difficult to ascertain. To …

… Author links open overlay panel Luis J Nannini Jr. MD a , Juan C Pendino MD b , Raul A
Corna MD c , Silvina Mannarino MD a , Raimundo Quispe MD d … LJ Nannini Jr … LJ Nannini Jr …

Background Some studies have suggested that use of long-acting β 2 -agonists (LABAs) leads
to an increased risk for adverse events in patients with stable COPD. The purpose of this …

A new generation of chiral gold(I) catalysts based on variations of complexes with JohnPhos-type
ligands with a remote C 2 -symmetric 2,5-diarylpyrrolidine have been synthesized with …

BACKGROUND: There are safety concerns regarding the use of anticholinergics in the COPD
patient population. The purpose of this review was to evaluate the cardiovascular risk of …

… (LABAs) and inhaled corticosteroids (ICS) is widely recommended in COPD, on the basis
of considerable trial evidence showing favourable effects in comparison with placebo (Nannini …

OBJECTIVE: To evaluate the efficacy of aerosolized adrenaline compared to inhaled β 2
agonists in the treatment of acute asthma in the emergency setting. DATA SOURCES: MEDLINE…